Response-guided Dosing
Response-Guided Dosing is a dose scheduling strategy in which the administration of therapeutic agents is dynamically adjusted based on individual patient responses, such as biomarker levels or clinical outcomes, to optimize efficacy and minimize toxicity.
6
Publications
196
Citations
77
Authors
47
Institutions
Publications per year
2017–2026
3
Parents
6
Börje S. Andersson, Peter F. Thall, Benigno C. Valdez et al. · Bone Marrow Transplantation · 2016 · 85 citations · Full text
Robert N. Schuck, Michael Pacanowski, Sarah Kim-McOlash et al. · Clinical and Translational Science · 2019 · 24 citations · Full text
Roy Fleischmann, John A. Goldman, Marjatta Leirisalo‐Repo et al. · Current Medical Research and Opinion · 2014 · 14 citations · Full text
1–5 of 6
77
The University of Texas MD Anderson Cancer Center, United States
1 publications · 14 citations
1
h-index
1
h-index
1
h-index
Amsterdam UMC Location University of Amsterdam, Netherlands
1 publications · 40 citations
1
h-index
Oklahoma Foundation for Digestive Research, United States
1 publications · 14 citations
1
h-index
1–5 of 77
47
Memorial Sloan Kettering Cancer Center
New York, United States
1 h-index
1 publications
14 citations
Jagiellonian University
Krakow, Poland
1 h-index
1 publications
14 citations

University of Helsinki
Helsinki, Finland
1 h-index
1 publications
14 citations

Janssen (Belgium)
Beerse, Belgium
1 h-index
4 publications
56 citations
Hospital del Salvador
Santiago, Chile
1 h-index
1 publications
14 citations
Center for Rheumatology
Albany, United States
1 h-index
1 publications
14 citations
Jan Biotech (United States)
Ithaca, United States
1 h-index
2 publications
28 citations

Imperial College London
London, United Kingdom
1 h-index
1 publications
14 citations
1–8 of 47
Repository · 1 publications · 19 citations
1
h-index
1 publications · 14 citations
1
h-index
JCC · 1 publications · 40 citations
1
h-index
1 publications · 85 citations
1
h-index
CTS · 1 publications · 24 citations
1
h-index
1–5